English

BIOCLINICA INC

EDGAR

Annual report (10-K) · filed 2013-02-22

69 filing records in this dataset, filed from 1996-07-31 to 2013-02-22. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

27.6 million Unit1

2012 Q4 · Unit1

Exact inputs and evidence

Revenue: 98278000 Unit1 Source
Revenue: 70671000 Unit1 Source

Operating margin

7.67%

2012 Q4 · %

Exact inputs and evidence

Operating Income: 6508000 Unit1 Source
Operating Income: 4390000 Unit1 Source
Revenue: 98278000 Unit1 Source
Revenue: 70671000 Unit1 Source

Operating cash flow

3.84 million Unit1

2012 Q4 · Unit1

Exact inputs and evidence

Operating Cash Flow: 9853000 Unit1 Source
Operating Cash Flow: 6014000 Unit1 Source

Free cash flow

3.23 million Unit1

2012 Q4 · Unit1

Exact inputs and evidence

Operating Cash Flow: 9853000 Unit1 Source
Operating Cash Flow: 6014000 Unit1 Source
Capital Expenditure: 3918000 Unit1 Source
Capital Expenditure: 3305000 Unit1 Source

Cash and cash equivalents: 13.9 million Unit1 2012-12-31 Source
Exact value

13915000 Unit1
Long-term debt including current maturities: Not available
Shares outstanding: 15.7 million Unit15 2012-12-31 Source
Exact value

15656146 Unit15

Reported share-count change

0.04% · 6.15 thousand Unit15

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

15649994 Unit15 · 2011-12-31· Source
15656146 Unit15 · 2012-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-02-22.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2012-12-31
Operating income: 4 of 11 periods available· newest 2012-12-31
Net income: 4 of 11 periods available· newest 2012-12-31
Operating cash flow: 4 of 11 periods available· newest 2012-12-31
Capital expenditure: 4 of 11 periods available· newest 2012-12-31
Total assets: 3 of 11 periods available· newest 2012-12-31
Total liabilities: 3 of 11 periods available· newest 2012-12-31
Current assets: 3 of 11 periods available· newest 2012-12-31
Current liabilities: 3 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2012-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17%

Prior period

Unit1 83.96 million

2011-01-01 – 2011-12-31
Current period

Unit1 98.28 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

98278000 − 83964000 = 14314000 Unit1

83964000 Unit1 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
98278000 Unit1 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Year-over-year change in Revenue: 14314000 Unit1 Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 98278000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#919911 Filing: 000110465913013229 Input fundies:Revenue: 83964000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#919788 Filing: 000110465913013229
The citation records this snapshot. The page link may show a newer release later.
Net income
+33.2%

Prior period

Unit1 2.8 million

2011-01-01 – 2011-12-31
Current period

Unit1 3.73 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

3727000 − 2798000 = 929000 Unit1

2798000 Unit1 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
3727000 Unit1 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Year-over-year change in Net income: 929000 Unit1 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 3727000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#682279 Filing: 000110465913013229 Input fundies:NetIncome: 2798000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681946 Filing: 000110465913013229
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+27.5%

Prior period

Unit1 7.73 million

2011-01-01 – 2011-12-31
Current period

Unit1 9.85 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

9853000 − 7726000 = 2127000 Unit1

7726000 Unit1 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
9853000 Unit1 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Year-over-year change in Operating cash flow: 2127000 Unit1 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 9853000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681423 Filing: 000110465913013229 Input fundies:OperatingCashFlow: 7726000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681233 Filing: 000110465913013229
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+110.8%

Prior period

Unit1 1.86 million

2011-01-01 – 2011-12-31
Current period

Unit1 3.92 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

3918000 − 1859000 = 2059000 Unit1

1859000 Unit1 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
3918000 Unit1 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Year-over-year change in Capital expenditure: 2059000 Unit1 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3918000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825404 Filing: 000110465913013229 Input fundies:CapitalExpenditure: 1859000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825214 Filing: 000110465913013229
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue Unit1 98.28 million 100% of revenue
Operating costs Derived Unit1 91.77 million 93% of revenue
Operating income Unit1 6.51 million 6.6% of revenue
Tax, interest and other Derived Unit1 2.78 million 2.8% of revenue
Net income Unit1 3.73 million 3.8% of revenue

Cash

Operating cash flow Unit1 9.85 million 10% of revenue
Capital expenditure Unit1 3.92 million 4% of revenue
Free cash flow Derived Unit1 5.94 million 6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 94%
2010 94%
2011 95%
2012 93%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	72723000	68035000 Derived	4688000	1729000 Derived	2959000	4789000 Derived	Source 2009-01-01 – 2009-12-31: 72723000 Unit1 Inspect Revenue Open source 2009-01-01 – 2009-12-31: 4688000 Unit1 Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 2959000 Unit1 Inspect Net Income Open source 2009-01-01 – 2009-12-31: 7552000 Unit1 Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 2763000 Unit1 Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	75188000	70870000 Derived	4318000	1565000 Derived	2753000	1076000 Derived	Source 2010-01-01 – 2010-12-31: 75188000 Unit1 Inspect Revenue Open source 2010-01-01 – 2010-12-31: 4318000 Unit1 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 2753000 Unit1 Inspect Net Income Open source 2010-01-01 – 2010-12-31: 3992000 Unit1 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 2916000 Unit1 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	83964000	79590000 Derived	4374000	1576000 Derived	2798000	5867000 Derived	Source 2011-01-01 – 2011-12-31: 83964000 Unit1 Inspect Revenue Open source 2011-01-01 – 2011-12-31: 4374000 Unit1 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 2798000 Unit1 Inspect Net Income Open source 2011-01-01 – 2011-12-31: 7726000 Unit1 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 1859000 Unit1 Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	98278000	91770000 Derived	6508000	2781000 Derived	3727000	5935000 Derived	Source 2012-01-01 – 2012-12-31: 98278000 Unit1 Inspect Revenue Open source 2012-01-01 – 2012-12-31: 6508000 Unit1 Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 3727000 Unit1 Inspect Net Income Open source 2012-01-01 – 2012-12-31: 9853000 Unit1 Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 3918000 Unit1 Inspect Capital Expenditure Open source

Amounts are exact, in Unit1.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit1 98.3M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit1)	Source evidence
20092009-12-31	Revenue	72723000	Revenue: 72723000 Open source
20102010-12-31	Revenue	75188000	Revenue: 75188000 Open source
20112011-12-31	Revenue	83964000	Revenue: 83964000 Open source
20122012-12-31	Revenue	98278000	Revenue: 98278000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 72723000 Open source
20102010-12-31	Year over year	3.4%	Revenue: 75188000 Open source Revenue: 72723000 Open source
20112011-12-31	Year over year	11.7%	Revenue: 83964000 Open source Revenue: 75188000 Open source
20122012-12-31	Year over year	17%	Revenue: 98278000 Open source Revenue: 83964000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 6.6% 2012

Net margin 3.8% 2012

Free cash flow margin 6% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	6.4%	Operating Income: 4688000 Open source Revenue: 72723000 Open source
20102010-12-31	Operating margin	5.7%	Operating Income: 4318000 Open source Revenue: 75188000 Open source
20112011-12-31	Operating margin	5.2%	Operating Income: 4374000 Open source Revenue: 83964000 Open source
20122012-12-31	Operating margin	6.6%	Operating Income: 6508000 Open source Revenue: 98278000 Open source
20092009-12-31	Net margin	4.1%	Net Income: 2959000 Open source Revenue: 72723000 Open source
20102010-12-31	Net margin	3.7%	Net Income: 2753000 Open source Revenue: 75188000 Open source
20112011-12-31	Net margin	3.3%	Net Income: 2798000 Open source Revenue: 83964000 Open source
20122012-12-31	Net margin	3.8%	Net Income: 3727000 Open source Revenue: 98278000 Open source
20092009-12-31	Free cash flow margin	6.6%	Revenue: 72723000 Open source Operating Cash Flow: 7552000 Open source Capital Expenditure: 2763000 Open source
20102010-12-31	Free cash flow margin	1.4%	Revenue: 75188000 Open source Operating Cash Flow: 3992000 Open source Capital Expenditure: 2916000 Open source
20112011-12-31	Free cash flow margin	7%	Revenue: 83964000 Open source Operating Cash Flow: 7726000 Open source Capital Expenditure: 1859000 Open source
20122012-12-31	Free cash flow margin	6%	Revenue: 98278000 Open source Operating Cash Flow: 9853000 Open source Capital Expenditure: 3918000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit1 9.9M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20092009-12-31	Operating cash flow	7552000	Operating Cash Flow: 7552000 Open source
20102010-12-31	Operating cash flow	3992000	Operating Cash Flow: 3992000 Open source
20112011-12-31	Operating cash flow	7726000	Operating Cash Flow: 7726000 Open source
20122012-12-31	Operating cash flow	9853000	Operating Cash Flow: 9853000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit1 5.9M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20092009-12-31	Free cash flow	4789000	Operating Cash Flow: 7552000 Open source Capital Expenditure: 2763000 Open source
20102010-12-31	Free cash flow	1076000	Operating Cash Flow: 3992000 Open source Capital Expenditure: 2916000 Open source
20112011-12-31	Free cash flow	5867000	Operating Cash Flow: 7726000 Open source Capital Expenditure: 1859000 Open source
20122012-12-31	Free cash flow	5935000	Operating Cash Flow: 9853000 Open source Capital Expenditure: 3918000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

38.2% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
20102010-12-31	Liabilities / assets	31.4%	Total Liabilities: 25150000 Open source Total Assets: 80029000 Open source
20112011-12-31	Liabilities / assets	35.8%	Total Liabilities: 32361000 Open source Total Assets: 90421000 Open source
20122012-12-31	Liabilities / assets	38.2%	Total Liabilities: 38542000 Open source Total Assets: 101006000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.5× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	1.43×	Current Assets: 28435000 Open source Current Liabilities: 19829000 Open source
20112011-12-31	Current assets / current liabilities	1.47×	Current Assets: 36308000 Open source Current Liabilities: 24753000 Open source
20122012-12-31	Current assets / current liabilities	1.5×	Current Assets: 42912000 Open source Current Liabilities: 28520000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	Unit1 2.96 million Exact value Exact value: 2959000 Unit1 2009-01-01 – 2009-12-31: 2959000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · BIOCLINICA INC · 2009-12-31 BIOCLINICA INC (edgar:822418) Net Income: 2959000 Unit1 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 2959000 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465912013167/bioc-20111231.xml#317541 Filing: 000110465912013167 The citation records this snapshot. The page link may show a newer release later.	Unit1 7.55 million Exact value Exact value: 7552000 Unit1 2009-01-01 – 2009-12-31: 7552000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCLINICA INC · 2009-12-31 BIOCLINICA INC (edgar:822418) Operating Cash Flow: 7552000 Unit1 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 7552000 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465912013167/bioc-20111231.xml#316971 Filing: 000110465912013167 The citation records this snapshot. The page link may show a newer release later.	Unit1 2.76 million Exact value Exact value: 2763000 Unit1 2009-01-01 – 2009-12-31: 2763000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCLINICA INC · 2009-12-31 BIOCLINICA INC (edgar:822418) Capital Expenditure: 2763000 Unit1 Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 2763000 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465912013167/bioc-20111231.xml#375298 Filing: 000110465912013167 The citation records this snapshot. The page link may show a newer release later.	Unit1 4.79 million Calculation and evidence 7552000 − 2763000 Unit1 Exact free cash flow: 4789000 Unit1 2009-01-01 – 2009-12-31: 7552000 Unit1 · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 2763000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCLINICA INC · 2009-12-31 BIOCLINICA INC (edgar:822418) Free cash flow: 4789000 Unit1 Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7552000 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465912013167/bioc-20111231.xml#316971 Filing: 000110465912013167 Input fundies:CapitalExpenditure: 2763000 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465912013167/bioc-20111231.xml#375298 Filing: 000110465912013167 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	Unit1 2.75 million Exact value Exact value: 2753000 Unit1 2010-01-01 – 2010-12-31: 2753000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · BIOCLINICA INC · 2010-12-31 BIOCLINICA INC (edgar:822418) Net Income: 2753000 Unit1 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 2753000 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681613 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 3.99 million Exact value Exact value: 3992000 Unit1 2010-01-01 – 2010-12-31: 3992000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCLINICA INC · 2010-12-31 BIOCLINICA INC (edgar:822418) Operating Cash Flow: 3992000 Unit1 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 3992000 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681043 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 2.92 million Exact value Exact value: 2916000 Unit1 2010-01-01 – 2010-12-31: 2916000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCLINICA INC · 2010-12-31 BIOCLINICA INC (edgar:822418) Capital Expenditure: 2916000 Unit1 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 2916000 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825024 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 1.08 million Calculation and evidence 3992000 − 2916000 Unit1 Exact free cash flow: 1076000 Unit1 2010-01-01 – 2010-12-31: 3992000 Unit1 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 2916000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCLINICA INC · 2010-12-31 BIOCLINICA INC (edgar:822418) Free cash flow: 1076000 Unit1 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3992000 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681043 Filing: 000110465913013229 Input fundies:CapitalExpenditure: 2916000 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825024 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unit1 2.8 million Exact value Exact value: 2798000 Unit1 2011-01-01 – 2011-12-31: 2798000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · BIOCLINICA INC · 2011-12-31 BIOCLINICA INC (edgar:822418) Net Income: 2798000 Unit1 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 2798000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681946 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 7.73 million Exact value Exact value: 7726000 Unit1 2011-01-01 – 2011-12-31: 7726000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCLINICA INC · 2011-12-31 BIOCLINICA INC (edgar:822418) Operating Cash Flow: 7726000 Unit1 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 7726000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681233 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 1.86 million Exact value Exact value: 1859000 Unit1 2011-01-01 – 2011-12-31: 1859000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCLINICA INC · 2011-12-31 BIOCLINICA INC (edgar:822418) Capital Expenditure: 1859000 Unit1 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 1859000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825214 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 5.87 million Calculation and evidence 7726000 − 1859000 Unit1 Exact free cash flow: 5867000 Unit1 2011-01-01 – 2011-12-31: 7726000 Unit1 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1859000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCLINICA INC · 2011-12-31 BIOCLINICA INC (edgar:822418) Free cash flow: 5867000 Unit1 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7726000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681233 Filing: 000110465913013229 Input fundies:CapitalExpenditure: 1859000 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825214 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unit1 3.73 million Exact value Exact value: 3727000 Unit1 2012-01-01 – 2012-12-31: 3727000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Net Income: 3727000 Unit1 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 3727000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#682279 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 9.85 million Exact value Exact value: 9853000 Unit1 2012-01-01 – 2012-12-31: 9853000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Operating Cash Flow: 9853000 Unit1 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 9853000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681423 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 3.92 million Exact value Exact value: 3918000 Unit1 2012-01-01 – 2012-12-31: 3918000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Capital Expenditure: 3918000 Unit1 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 3918000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825404 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.	Unit1 5.94 million Calculation and evidence 9853000 − 3918000 Unit1 Exact free cash flow: 5935000 Unit1 2012-01-01 – 2012-12-31: 9853000 Unit1 · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 3918000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCLINICA INC · 2012-12-31 BIOCLINICA INC (edgar:822418) Free cash flow: 5935000 Unit1 Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/822418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9853000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#681423 Filing: 000110465913013229 Input fundies:CapitalExpenditure: 3918000 Unit1 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822418/000110465913013229/bioc-20121231.xml#825404 Filing: 000110465913013229 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 759 latest values · 759 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000822418, 822418, bioc, edgar:822418

Also known as BIO IMAGING TECHNOLOGIES INC, BIOCLINICA INC

BIOCLINICA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation